Exact Mass: 631.2788036000001
Exact Mass Matches: 631.2788036000001
Found 136 metabolites which its exact mass value is equals to given mass value 631.2788036000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Mesaconitine
Mesaconitine is a diterpenoid. Mesaconitine is a natural product found in Aconitum anthora, Aconitum napellus, and other organisms with data available. Origin: Plant; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Aconitum alkaloid Annotation level-1 Mesaconitine is the main active component of genus aconitum plants. IC50 value: Target: in vitro: In HUVECs, 30 microM mesaconitine increased the [Ca(2+)](i) level in the presence of extracellular CaCl(2) and NaCl, and the response was inhibited by KBR7943. Mesaconitine increased intracellular Na(+) concentration level in HUVECs. The [Ca(2+)](i) response by mesaconitine was inhibited by 100 microM D-tubocurarine [1]. Mesaconitine at 30 microM inhibited 3 microM phenylephrine-induced contraction in the endothelium-intact, but not endothelium-denuded, aortic rings [2]. MA promoted the alpha-MT-induced decrease in NE levels in hippocampus, medulla oblongata plus pons and spinal cord [3]. Mesaconitine is the main active component of genus aconitum plants. IC50 value: Target: in vitro: In HUVECs, 30 microM mesaconitine increased the [Ca(2+)](i) level in the presence of extracellular CaCl(2) and NaCl, and the response was inhibited by KBR7943. Mesaconitine increased intracellular Na(+) concentration level in HUVECs. The [Ca(2+)](i) response by mesaconitine was inhibited by 100 microM D-tubocurarine [1]. Mesaconitine at 30 microM inhibited 3 microM phenylephrine-induced contraction in the endothelium-intact, but not endothelium-denuded, aortic rings [2]. MA promoted the alpha-MT-induced decrease in NE levels in hippocampus, medulla oblongata plus pons and spinal cord [3].
Efonidipine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D000077264 - Calcium-Regulating Hormones and Agents D045283 - Natriuretic Agents > D004232 - Diuretics D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Gliadins
Isolated from wheat flour or wheat gluten
Mesaconitine
PC(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))
PC(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Lipoxin A5 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).
PC(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0)
PC(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0), in particular, consists of one chain of one Lipoxin A5 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).
tricaffeoyl spermidine
C34H37N3O9 (631.2529672000001)
Tricaffeoyl spermidine belongs to hydroxycinnamic acids and derivatives class of compounds. Those are compounds containing an cinnamic acid (or a derivative thereof) where the benzene ring is hydroxylated. Tricaffeoyl spermidine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Tricaffeoyl spermidine can be found in a number of food items such as black radish, breadfruit, persimmon, and jicama, which makes tricaffeoyl spermidine a potential biomarker for the consumption of these food products.
1beta,7beta,11-triacetoxy-4alpha-hydroxy-5alpha-nicotinoyl-8-alpha-tiglyloxydihydroagarofuran|triptersinine L
C32H41NO12 (631.2628626000001)
Asp Arg Arg Trp
Asp Arg Trp Arg
Asp Trp Arg Arg
Phe Phe Arg Tyr
C33H41N7O6 (631.3118165999999)
Phe Phe Tyr Arg
C33H41N7O6 (631.3118165999999)
Phe Arg Phe Tyr
C33H41N7O6 (631.3118165999999)
Phe Arg Tyr Phe
C33H41N7O6 (631.3118165999999)
Phe Tyr Phe Arg
C33H41N7O6 (631.3118165999999)
Phe Tyr Arg Phe
C33H41N7O6 (631.3118165999999)
Ile Gln Trp Trp
C33H41N7O6 (631.3118165999999)
Ile Trp Gln Trp
C33H41N7O6 (631.3118165999999)
Ile Trp Trp Gln
C33H41N7O6 (631.3118165999999)
Leu Gln Trp Trp
C33H41N7O6 (631.3118165999999)
Leu Trp Gln Trp
C33H41N7O6 (631.3118165999999)
Leu Trp Trp Gln
C33H41N7O6 (631.3118165999999)
Met Arg Tyr Tyr
C29H41N7O7S (631.2788036000001)
Met Tyr Arg Tyr
C29H41N7O7S (631.2788036000001)
Met Tyr Tyr Arg
C29H41N7O7S (631.2788036000001)
Gln Ile Trp Trp
C33H41N7O6 (631.3118165999999)
Gln Leu Trp Trp
C33H41N7O6 (631.3118165999999)
Gln Trp Ile Trp
C33H41N7O6 (631.3118165999999)
Gln Trp Leu Trp
C33H41N7O6 (631.3118165999999)
Gln Trp Trp Ile
C33H41N7O6 (631.3118165999999)
Gln Trp Trp Leu
C33H41N7O6 (631.3118165999999)
Arg Asp Arg Trp
Arg Asp Trp Arg
Arg Phe Phe Tyr
C33H41N7O6 (631.3118165999999)
Arg Phe Tyr Phe
C33H41N7O6 (631.3118165999999)
Arg Met Tyr Tyr
C29H41N7O7S (631.2788036000001)
Arg Arg Asp Trp
Arg Arg Trp Asp
Arg Trp Asp Arg
Arg Trp Arg Asp
Arg Tyr Phe Phe
C33H41N7O6 (631.3118165999999)
Arg Tyr Met Tyr
C29H41N7O7S (631.2788036000001)
Arg Tyr Tyr Met
C29H41N7O7S (631.2788036000001)
Thr Trp Tyr Tyr
Thr Tyr Trp Tyr
Thr Tyr Tyr Trp
Trp Asp Arg Arg
Trp Ile Gln Trp
C33H41N7O6 (631.3118165999999)
Trp Ile Trp Gln
C33H41N7O6 (631.3118165999999)
Trp Leu Gln Trp
C33H41N7O6 (631.3118165999999)
Trp Leu Trp Gln
C33H41N7O6 (631.3118165999999)
Trp Gln Ile Trp
C33H41N7O6 (631.3118165999999)
Trp Gln Leu Trp
C33H41N7O6 (631.3118165999999)
Trp Gln Trp Ile
C33H41N7O6 (631.3118165999999)
Trp Gln Trp Leu
C33H41N7O6 (631.3118165999999)
Trp Arg Asp Arg
Trp Arg Arg Asp
Trp Thr Tyr Tyr
Trp Trp Ile Gln
C33H41N7O6 (631.3118165999999)
Trp Trp Leu Gln
C33H41N7O6 (631.3118165999999)
Trp Trp Gln Ile
C33H41N7O6 (631.3118165999999)
Trp Trp Gln Leu
C33H41N7O6 (631.3118165999999)
Trp Tyr Thr Tyr
Trp Tyr Tyr Thr
Tyr Phe Phe Arg
C33H41N7O6 (631.3118165999999)
Tyr Phe Arg Phe
C33H41N7O6 (631.3118165999999)
Tyr Met Arg Tyr
C29H41N7O7S (631.2788036000001)
Tyr Met Tyr Arg
C29H41N7O7S (631.2788036000001)
Tyr Arg Phe Phe
C33H41N7O6 (631.3118165999999)
Tyr Arg Met Tyr
C29H41N7O7S (631.2788036000001)
Tyr Arg Tyr Met
C29H41N7O7S (631.2788036000001)
Tyr Thr Trp Tyr
Tyr Thr Tyr Trp
Tyr Trp Thr Tyr
Tyr Trp Tyr Thr
Tyr Tyr Met Arg
C29H41N7O7S (631.2788036000001)
Tyr Tyr Arg Met
C29H41N7O7S (631.2788036000001)
Tyr Tyr Thr Trp
Tyr Tyr Trp Thr
Gliadin
5(6)-CARBOXY-X-RHODAMINE-N-HYDROXYSUCCINIMIDE ESTER
C37H33N3O7 (631.2318388000001)
6-Carboxy-X-rhodamine succinimidyl ester,6-ROX, SE
C37H33N3O7 (631.2318388000001)
Mgb-BP-3
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D004214 - Distamycins
3-(7-Benzyl-4,5-dihydroxy-1,1-dioxo-3,6-bis-phenoxymethyl-1L6-[1,2,7]thiadiazepan-2-ylmethyl)-N-methyl-benzamide
C34H37N3O7S (631.2352092000001)
Efonidipine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D000077264 - Calcium-Regulating Hormones and Agents D045283 - Natriuretic Agents > D004232 - Diuretics D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
6-[(3S,6S,9S,12R)-3-benzyl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.3.0]pentadecan-9-yl]hexanoic acid
3-(4-fluorophenyl)-1-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
(1r,2s,3s,5r,7s,10s,11s,12s,15r,16s,17r,19s)-8-ethyl-15,17-dihydroxy-3,12,16-trimethoxy-10-(methoxymethoxy)-6-oxa-8-azahexacyclo[15.2.1.0²,⁷.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]icos-13-en-18-yl 4-methoxybenzoate
(1s,2r,3r,4r,5r,6s,7s,8r,9r,10r,13r,14r,16s,17s,18r)-8-(acetyloxy)-11-ethyl-5,7,14,16-tetrahydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate
(2e)-3-(3,4-dihydroxyphenyl)-n-{3-[(2e)-3-(3,4-dihydroxyphenyl)-n-(4-{[(2e)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}butyl)prop-2-enamido]propyl}prop-2-enimidic acid
C34H37N3O9 (631.2529672000001)
8-(acetyloxy)-11-ethyl-5,7,14,16-tetrahydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate
4-methylaconitane-1,6,8,10,13,14,15,16,18-nonol; (1α,6α,14α,15α,16β)-form,o6,o16,o18-tri-me,14-benzoyl,8-ac,n-formyl
C32H41NO12 (631.2628626000001)
{"Ingredient_id": "HBIN010680","Ingredient_name": "4-methylaconitane-1,6,8,10,13,14,15,16,18-nonol; (1\u03b1,6\u03b1,14\u03b1,15\u03b1,16\u03b2)-form,o6,o16,o18-tri-me,14-benzoyl,8-ac,n-formyl","Alias": "NA","Ingredient_formula": "C32H41NO12","Ingredient_Smile": "NA","Ingredient_weight": "631.67","OB_score": "NA","CAS_id": "125286-17-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7779","PubChem_id": "NA","DrugBank_id": "NA"}
(1s,2r,3r,4r,5r,6s,7s,8r,9r,10r,13r,14r,16s,17s,18r)-8-(acetyloxy)-5,7,14-trihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate
n-{2-[hydroxy({3-[(4r)-1-[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-2,2,3-trimethyl-5-oxoimidazolidin-4-yl]propyl})carbamoyl]ethyl}-2-({hydroxy[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)ethanimidic acid
(2s)-3-{[(1r,9s,10s,12s,14e,16s,19r,20r,21s,22r)-3,9-dihydroxy-10,12,14,16,20,21,22-heptamethyl-4-oxo-23,24-dioxatetracyclo[17.3.1.1⁶,⁹.0²,⁷]tetracosa-2,5,7,14-tetraen-8-yl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid
C34H49NO8S (631.3178714000001)
(1s,2r,3r,4r,5r,6s,7s,8r,9r,10r,13r,14r,16r,17s,18r)-8-(acetyloxy)-5,7,14-trihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate
3-(3,4-dihydroxyphenyl)-n-{3-[3-(3,4-dihydroxyphenyl)-n-(4-{[3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}butyl)prop-2-enamido]propyl}prop-2-enimidic acid
C34H37N3O9 (631.2529672000001)
3-({3,9-dihydroxy-10,12,14,16,20,21,22-heptamethyl-4-oxo-23,24-dioxatetracyclo[17.3.1.1⁶,⁹.0²,⁷]tetracosa-2,5,7,14-tetraen-8-yl}sulfanyl)-2-[(1-hydroxyethylidene)amino]propanoic acid
C34H49NO8S (631.3178714000001)